Ketoconazole-pamam Dendrimer Supramolecular Complex for Prolonged Delivery by In Vitro and In Vivo Studies
DOI:
https://doi.org/10.24193/subbchem.2023.4.10Keywords:
Ketoconazole, PAMAM dendrimer, Drug-dendrimer complex, Solubility, Cell viability, Mouse ear sensitization testAbstract
The current study investigates the potential of the supramolecular complex between the antifungal agent Ketoconazole (KTZ) and PAMAM dendrimer G5 generation to be used as a topically applied antimycotic drug. The new drug-dendrimer formulation was confirmed by combining XRPD, FT-IR and DSC analytical techniques, and presents improved aqueous solubility and delayed in vitro release profile compare to pure KTZ. The biological assays data showed the biocompatibility of the supramolecular complex and improved delivery of the encapsulated KTZ into the superficial layers of skin and mucosa at the mycotic infections site, leading to a better outcome of the infection.
References
A. H. Groll; J. Lumb; Future Microbiol., 2012, 7, 179-184
D. T. Mlynarczyk; J. Dlugaszewska; A. Kaluzna-Mlynarczyk; T. Goslinski; JCR, 2021, 330, 599-617
G. L. Amidon; H. Lennernäs; V. P. Shah; J. R. Crison; Pharm Res., 1995, 12(3), 413-420
S. Basa; T. Muniyappan; P. Karatgi; R. Prabhu; R. Pillai; Drug. Dev. Ind. Pharm., 2008, 34, 1209-1218
E. N. Lo; L. A. Beckett; C. -X. Pan; D. Robles; J. M. Suga; J. M. Sands; P. N. Lara; Prostate. Cancer. Prostatic. Dis., 2015, 18, 144-148
European Medicines Agency. Ketoconazole HRA; http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003906/human_med_001814.jsp&mid=WC0b01ac058001d124.
F. D. Choi; M. L. W. Juhasz; N. A. Mesinkovska; J. Dermatolog. Treat., 2019, 30(8), 760-771
F. A. Martin; M. M. Pop; G. Borodi; X. Filip; I. Kacso; Cryst. Growth. Des., 2013, 13(10), 4295-4304
I. Kacso; L. M. Rus; F. Martin; M. Miclaus; X. Filip, M. Dan; J. Therm. Anal. Calorim., 2021, 143, 3499-3506
F. Martin; M. Pop; I. Kacso; I. G. Grosu; M. Miclăuş; D. Vodnar; I. Lung; G. A. Filip; E. D. Olteanu; R. Moldovan; A. Nagy; X. Filip; I. Bâldea; Molec. Pharmaceutics, 2020, 17(3), 919-932
X. Chen; D. Li; Z. Deng; H. Zhang; Cryst. Growth Des., 2020, 20, 6973-6982
A. K. Aggarwal; S. Jain; Chem. Pharm. Bull., 2011, 59, 629-638
P. K. Mididoddi; M. A. Repka; Eur. J. Pharm. Biopharm., 2007, 66, 95-105
J. Taraszewska; M. J. Kozbial; Inclusion Phenom. Mol. Recognit. Chem., 2005, 53, 155-161
A.S. Chauhan; Molecules, 2018, 23(4), 938-947
A. Santos; F. Veiga; A. Figueiras; Materials, 2020, 13(65), 1-31
V. Patel; P. Patel; J. V. Patel; P. M. Patel; J. Indian Chem. Society, 2022, 99(7), 100516
N. P. Silva JR; F. P. Menacho; M. Chorilli; J. Pharma., 2012, 2, 23-30
R.V. de Araújo; S. da Silva Santos; F. E. Igne; J. Giarolla; Molecules, 2018, 23, 2849-2876
K. Winnicka; M. Wroblewska; P. Wieczorek; P.T. Sacha; E. Tryniszewska; Molecules, 2012, 17, 4612-4624
J. Jose; R. N. Charyulu; Optoelectronics and advanced materials – Rapid Communications, 2016, 10(7-8), 604–608
A. Chauhana; B. Antona; M. K. Singh; Dendrimers for drug solubilization, dissolution and bioavailability, in Pharmaceutical Applications of Dendrimers, A. Chauhan, H. Kulhari Eds.; Elsevier, 2019, Chapter 3, pp. 59-92
B. Yavuz; S. B. Pehlivan; N. Unlu; Sci. World J., 2013, 732340
S. Svenson; Chem. Soc. Rev., 2015, 44(12), 4131-44
P. Papneja; M. Kumar Kataria; A. Bilandi; EJPMR, 2015, 2(5), 990-1014
A. Karolewicz; A. Górniak; E. Owczarek; A. Żurawska-Plaksej; J. Pluta Piwowar; J. Therm. Anal. Calorim., 2014, 115, 2487-2493
S. Uppuluri; P. R. Dvornic; J. W. Klimash; P. I. Carver; N. C. Beck Tan; The Properties of Dendritic Polymers I: Generation 5 Poly(amidoamine) Dendrimers, 2022
C. D. Bevan; R. S. Lloyd; Anal. Chem., 2000, 72(8), 1781-1787
S. D’Souza; Advances in Pharmaceutics, 2014, Art. ID 304757, 1-12
J. Jose; R. N. Charyulu; Int. J. Pharm. Investig., 2016, 6(2), 123-127
J. ‐L. Garrigue; J. ‐F. Nicolas; R. Fraginals; C. Benezra; H. Bour; D. Schmitt; Contact Dermatitis., 1994, 30(4), 231-237
P. S. Thorne; C. Hawk; S. D. Kaliszewski; P. D. Guiney; Fundam. Appl. Tox., 1991, 17, 807-820
C. G. Shayne; J. D. Brendan; D. W. Dobbs, C. Reilly, R. D.Walsh, Toxicol and Applied Pharmacol, 1986, 84:(1), 93-114
L. Tordesillas; R. Goswami; S. Benedé; G. Grishina; D. Dunkin; K. M. Järvinen; S. J. Maleki; H. A. Sampson; M. C. Berin; J. Clin. Invest. 2014, 124(11), 4965-7
S. Danescu; G. A. Filip; R. Moldovan; D. Olteanu; A. Nagy; X. Filip; F. Martin; I. Kacso; I. Baldea; Inflammopharmacology, 2021, 29(3), 721-733.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Studia Universitatis Babeș-Bolyai Chemia
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.